BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 19861194)

  • 1. Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL.
    Hong SM; Park CH; Lee JH
    Otolaryngol Head Neck Surg; 2009 Nov; 141(5):579-83. PubMed ID: 19861194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.
    Plontke SK; Löwenheim H; Mertens J; Engel C; Meisner C; Weidner A; Zimmermann R; Preyer S; Koitschev A; Zenner HP
    Laryngoscope; 2009 Feb; 119(2):359-69. PubMed ID: 19172627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss.
    Park MK; Lee CK; Park KH; Lee JD; Lee CG; Lee BD
    Otolaryngol Head Neck Surg; 2011 Dec; 145(6):1016-21. PubMed ID: 21817157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study.
    Wu HP; Chou YF; Yu SH; Wang CP; Hsu CJ; Chen PR
    Otol Neurotol; 2011 Jul; 32(5):774-9. PubMed ID: 21646929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study.
    Xenellis J; Papadimitriou N; Nikolopoulos T; Maragoudakis P; Segas J; Tzagaroulakis A; Ferekidis E
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):940-5. PubMed ID: 16730534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss.
    Arslan N; Oğuz H; Demirci M; Şafak MA; İslam A; Kaytez SK; Samim E
    Otol Neurotol; 2011 Apr; 32(3):393-7. PubMed ID: 21221047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of 3 different steroid treatments for sudden sensorineural hearing loss: a prospective, randomized trial.
    Lim HJ; Kim YT; Choi SJ; Lee JB; Park HY; Park K; Choung YH
    Otolaryngol Head Neck Surg; 2013 Jan; 148(1):121-7. PubMed ID: 23077155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of idiopathic sudden sensorineural hearing loss using pulse therapy: a prospective, randomized, double-blind clinical trial.
    Westerlaken BO; de Kleine E; van der Laan B; Albers F
    Laryngoscope; 2007 Apr; 117(4):684-90. PubMed ID: 17415139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss.
    Battaglia A; Burchette R; Cueva R
    Otol Neurotol; 2008 Jun; 29(4):453-60. PubMed ID: 18401285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratympanic dexamethasone for profound idiopathic sudden sensorineural hearing loss.
    Battista RA
    Otolaryngol Head Neck Surg; 2005 Jun; 132(6):902-5. PubMed ID: 15944562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy.
    Gouveris H; Selivanova O; Mann W
    Eur Arch Otorhinolaryngol; 2005 Feb; 262(2):131-4. PubMed ID: 15747106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can intratympanic dexamethasone added to systemic steroids improve hearing outcome in patients with sudden deafness?
    Ahn JH; Yoo MH; Yoon TH; Chung JW
    Laryngoscope; 2008 Feb; 118(2):279-82. PubMed ID: 17989574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic sudden sensorineural hearing loss in the only hearing ear: patient characteristics and hearing outcome.
    Stahl N; Cohen D
    Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):193-5. PubMed ID: 16490878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of steroid administration methods in patients with idiopathic sudden sensorineural hearing loss: a retrospective observational study.
    Kim SH; Jung SY; Kim MG; Byun JY; Park MS; Yeo SG
    Clin Otolaryngol; 2015 Jun; 40(3):183-90. PubMed ID: 25346100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratympanic dexamethasone injection for refractory sudden sensorineural hearing loss.
    Choung YH; Park K; Shin YR; Cho MJ
    Laryngoscope; 2006 May; 116(5):747-52. PubMed ID: 16652082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saccular damage in patients with idiopathic sudden sensorineural hearing loss without vertigo.
    Hong SM; Byun JY; Park CH; Lee JH; Park MS; Cha CI
    Otolaryngol Head Neck Surg; 2008 Oct; 139(4):541-5. PubMed ID: 18922341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of sensorineural hearing loss in acute viral otitis media with intratympanic dexamethasone and hyaluronic acid in comparison with intravenous therapy].
    Stenner M; Jecker P; Gouveris H; Mann W
    Laryngorhinootologie; 2006 Jan; 85(1):32-7. PubMed ID: 16444653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic sudden sensorineural hearing loss in children.
    Chen YS; Emmerling O; Ilgner J; Westhofen M
    Int J Pediatr Otorhinolaryngol; 2005 Jun; 69(6):817-21. PubMed ID: 15885335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment.
    Ho HG; Lin HC; Shu MT; Yang CC; Tsai HT
    Laryngoscope; 2004 Jul; 114(7):1184-9. PubMed ID: 15235345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.